Key Highlights
•
A new study tracked tuberculosis (TB) cases in the United States from 2010 through 2023, revealing how the COVID-19 pandemic affected TB trends. This analysis is crucial for public health officials to understand the pandemic’s impact on other infectious diseases and to plan future TB control strategies.
Source →
•
Researchers argue that eliminating hepatitis B globally requires more than just new drugs or vaccines; it demands fixing long-standing unfairness in who gets to lead and benefit from the research. This perspective highlights a major barrier to global health equity and calls for a fundamental shift in how international medical partnerships are built.
Source →
•
A study found that a simple, non-invasive ultrasound method (transperineal ultrasound) could be as accurate as a more complex endoscopic procedure for assessing inflammation in patients with ulcerative colitis. This could lead to a more comfortable and accessible way to monitor this chronic bowel disease.
Source →
•
An artificial intelligence model was developed to help pathologists diagnose a rare and deadly liver cancer called intrahepatic cholangiocarcinoma, which is often confused with cancers that have spread from other organs. This tool could speed up accurate diagnosis, reduce unnecessary tests for patients, and lower healthcare costs.
Source →
•
A cost-effectiveness analysis from the UK’s National Health Service found that starting patients with heart failure on a powerful combination of four drugs right away is more cost-effective than the traditional step-by-step approach. This finding supports a major change in treatment strategy that could improve patient survival and reduce hospital visits while using healthcare money wisely.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
